Atomo Diagnostics (ASX:AT1) Common Stock: A$73.07 Mil (As of Dec. 2025)


What is Atomo Diagnostics Common Stock?

Atomo Diagnostics ASX:AT1 Common Stock is A$73.07 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Atomo Diagnostics's quarterly common stock increased from Dec. 2024 (A$70.09 Mil) to Jun. 2025 (A$71.84 Mil) and increased from Jun. 2025 (A$71.84 Mil) to Dec. 2025 (A$73.07 Mil).

Atomo Diagnostics's annual common stock increased from Jun. 2023 (A$68.04 Mil) to Jun. 2024 (A$70.09 Mil) and increased from Jun. 2024 (A$70.09 Mil) to Jun. 2025 (A$71.84 Mil).

Atomo Diagnostics Common Stock Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics Common Stock Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 67.92 68.04 68.04 70.09 71.84

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.09 70.09 70.09 71.84 73.07

Atomo Diagnostics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$73.07 Mil mean?
Atomo Diagnostics (ASX:AT1) has a Common Stock of A$73.07 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Atomo Diagnostics and its competitors.
Is Atomo Diagnostics' Common Stock too high?
Atomo Diagnostics' current Common Stock is A$73.07 Mil.
How does Atomo Diagnostics' Common Stock compare to ABT and SYK?
Atomo Diagnostics' Common Stock of A$73.07 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Atomo Diagnostics and its competitors. Atomo Diagnostics's current Common Stock is A$73.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 10% below its estimated fair value. The current Common Stock is A$73.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current Common Stock is A$73.07 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.